Reportlinker.com announces that a new market research report is available in its catalogue: The Global Market for Stem Cells
This BCC Research report provides detailed market, technology, and industry analyses to quantify and qualify the global market for prescription drug products. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2018.
Use this report to:
- Quantify and qualify the stem cell research market for prescription drug products.
- Receive information about stem cell technology and its practical applications.
- Understand how the regulatory environment, healthcare policies, demographics, and other factors directly affect the stem cell-related drug market.
- Learn about the nature and structure of the stem cell industry along with profiles of the leading companies.
- BCC Research projects that the global stem cell market will grow from about $5.6 billion in 2013 to nearly $10.6 billion in 2018, registering a compound annual growth rate (CAGR) of 3.6% from 2013 through 2018.
- The Americas is the largest region of global stem cell market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018.
- Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.
STUDY GOALS AND OBJECTIVES
The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription drug products.
Important trends are identified and sales forecasts by product categories and major country markets are provided through 2018; these are based on industry sources and
considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the stem cell-related drug market.
The wider economic environment is also taken into account.
The report examines strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market.
REASONS FOR DOING THE STUDY
Although products based on stem cells do not yet form an established market, unlike some other potential applications of bioscience, stem cell technology has already
produced a number of significant products in important therapeutic areas. This is because the possibilities for successful stem cell therapy are almost beyond estimation,
and the urgent need to develop this field is overriding the established, step-by-step approach to proceeding from basic science to practical applications. The potential
scope of the stem cell market is now becoming clear, and it is appropriate to review the technology, see its practical applications so far, evaluate the participating
companies and look to its future.
SCOPE OF REPORT
This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global
terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.
MARKET ANALYSES AND FORECASTS
Market figures are based on revenues at the manufacturer level and are projected at 2014-dollar value without attempting to predict the effect of inflation/deflation.
Therapeutic categories quantified and forecast include cancer, CNS diseases, infections and cardiovascular. Major country markets in three regions—Americas, Europe and
Asia—are analyzed and forecast, with a summary for the rest of the world.
Both primary and secondary research methodologies were used in preparing this study. Primary research includes interviews with leading individuals in stem cell companies
and industry associations. Primary sources of published data include company annual reports, SEC filings, and government and industry publications. Secondary sources
consist of literature searches, industry journals and other commercial publications. Data for market estimates and forecasts are pooled from a range of sources, critically
assessed by BCC Research.
This report is designed to satisfy the information needs of a wide variety of individuals involved in the pharmaceutical marketplace, including company senior management
executives seeking to base their strategic decisions on the best available information on market forces and trends. However, it is also aimed at managers and executives in
marketing, research, planning and sales departments who need readable, comprehensive and up-to-date background on the marketplace in which they are operating.
Sources of information included marketing strategists, industry executives, government agencies and regulatory bodies, and surveys of physicians and pharmacists. Company annual reports and SEC filings, journal articles, and data from healthcare institutions were also reviewed.